STOCKHEAD: Analyst Reckons Parkway has Potential to be 50-bagger
Independent Investment Research (IIR) has flagged that Parkway’s innovative tech for treatment of coal seam gas (CSG) brine could become best available technology (BAT) with a solid financial uptick for shareholders.
IIR has a risked base case valuation of $0.083 per share, a 10-fold increase on the current Parkway Corporate (ASX:PWN) price of $0.008/share, making it a potential 10-bagger, with further upside in an unrisked scenario.
IIR performed a detailed evaluation, and based on its own analysis of PWN found the company had disruptive, flexible, and low-cost tech, no competition at this stage and with strongly leverage earnings potential, in a growing market. Together with key personnel with skin in the game, the analyst noted great alignment between the company and shareholders.
The IIR Report can be accessed by visiting:
The Master Plan, which forms the basis for a large proportion of the valuation referenced in the IIR Report, can be accessed at: